Press Releases Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
7,27,000 ^KRW	-0.68%		-3.07%	-4.34%

06/06	Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	DJ
31/05	Samsung Biologics Aims to Lower Greenhouse Gas Emissions by 2030	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Samsung Biologics : Innovative solutions for bioprocessing challenges how MSAT drives efficient tech transfer	27/05	PU
Samsung Biologics Reports First Quarter 2024 Financial Results	25/04	AQ
Samsung Life Science Fund Invests in BrickBio	20/03	AQ
CEO IR Newsletter : 2024 AGM Wrap Up	15/03	PU
Samsung Biologics : hosts 13th Annual General Meeting of Shareholders	15/03	PU
Samsung Biologics signs MOU with Seoul National University to foster bio experts	01/03	AQ
Samsung Biologics awarded Leadership status by CDP for climate action efforts	14/02	AQ
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing	08/02	AQ
Samsung chair found not guilty of charges connected to 2015 merger	05/02	AQ
Samsung chief Lee Jae-yong is acquitted of financial crimes related to 2015 merger	05/02	AQ
Samsung chief acquitted in controversial 2015 merger case	05/02	AQ
Samsung C&T to invest in future growth and enhance shareholder value on foundation of steady performance	01/02	AQ
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating	23/01	AQ
Samsung Biologics : to present at the 42nd Annual J.P. Morgan Healthcare Conference	26/12	PU
S-Glyn™ : Optimizing N-Glycan profiles and their effector functions using a Design-of-Experiments approach	17/12	PU
Samsung Biologics engages suppliers to advance global decarbonization targets	29/11	AQ
Prosecutor requests 5 years in prison for Samsung president over fraud	17/11	AQ
Samsung Biologics Reports Third Quarter 2023 Financial Results	26/23/26	AQ
Samsung Biologics : to showcase strengthened development capabilities and business expansion updates at CPHI 2023	19/23/19	PU
Samsung Biologics Reports Second Quarter 2023 Financial Results	26/23/26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Samsung Biologics Co.,Ltd.

Equities

A207940

KR7207940008

Press Releases

Filters